168 | Chapter 6 References [1] Sturgis EM, Ang KK. The epidemic of HPV-associated oropharyngeal cancer is here: is it time to change our treatment paradigms? J Natl Compr Cancer Netw JNCCN 2011; 9: 665–673. [2] Ndiaye C, Mena M, Alemany L, et al. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. The LancetOncology 2014; 15: 1319–1331. [3] Shaw R, Robinson M. The increasing clinical relevance of human papillomavirus type 16 (HPV-16) infection in oropharyngeal cancer. Br J Oral Maxillofac Surg 2011; 49: 423–429. [4] Mehanna H, Beech T, Nicholson T, et al. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer–systematic review and meta-analysis of trends by time and region. Head Neck 2013; 35: 747–755. [5] Gillison ML, Chaturvedi AK, Anderson WF, et al. Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma. J Clin Oncol Off J Am Soc Clin Oncol 2015; 33: 3235–3242. [6] Ferris RL, Flamand Y, Weinstein GS, et al. Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311). J Clin Oncol Off J Am Soc Clin Oncol 2022; 40: 138–149. [7] Almeida JR de, Li R, Magnuson JS, et al. Oncologic Outcomes After Transoral Robotic Surgery: A Multiinstitutional Study. JAMA Otolaryngol Head Neck Surg 2015; 141: 1043–1051. [8] Nichols AC, Theurer J, Prisman E, et al. Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR Trial. J Clin Oncol 2022; JCO.21.01961. [9] Leinweber KA, Columbo JA, Kang R, et al. A Review of Decision Aids for Patients Considering More Than One Type of Invasive Treatment. J Surg Res 2019; 235: 350–366. [10] Stacey D, Légaré F, Lewis K, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. Epub ahead of print 2017. DOI: 10.1002/14651858.CD001431.pub5. [11] Petersen JF, Berlanga A, Stuiver MM, et al. Improving decision making in larynx cancer by developing a decision aid: A mixed methods approach. The Laryngoscope 2019; 129: 2733–2739. [12] Bigelow EO, Windon MJ, Fakhry C, et al. Development of a web-based, patient-centered decision aid for oropharyngeal cancer treatment. Oral Oncol 2021; 123: 105618. [13] Elwyn G, O’Connor A, Stacey D, et al. Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. BMJ 2006; 333: 417. [14] Elwyn G, Kreuwel I, Durand MA, et al. How to develop web-based decision support interventions for patients: a process map. Patient Educ Couns 2011; 82: 260–265. [15] Nichols AC, Theurer J, Prisman E, et al. Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial. The LancetOncology 2019; 20: 1349–1359. [16] Stelmes JJ, Gregoire V, Poorten VV, et al. Organ Preservation and Late Functional Outcome in Oropharyngeal Carcinoma: Rationale of EORTC 1420, the ‘Best of’ Trial. Front Oncol 2019; 9: 999. [17] O’Sullivan B, Huang SH, Su J, et al. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study. Lancet Oncol 2016; 17: 440–451. [18] International language standards | Cambridge English, https://www.cambridgeenglish.org/exams-andtests/cefr/ (accessed 11 April 2023). [19] Visiedocument Medisch Specialist 2025-DEF.pdf, https://demedischspecialist.nl/sites/default/files/ Visiedocument%20Medisch%20Specialist%202025-DEF.pdf (accessed 18 April 2023). [20] Campagne. Begin een goed gesprek, https://begineengoedgesprek.nl/campagne (accessed 18 April 2023). [21] ter Stege JA, Raphael DB, Oldenburg HSA, et al. Development of a patient decision aid for patients with breast cancer who consider immediate breast reconstruction after mastectomy. Health Expect 2022; 25: 232–244.
RkJQdWJsaXNoZXIy MTk4NDMw